FloBio is developing a novel point of care diagnostic platform for the rapid assessment of bleeding & clotting risk in emergency critical care settings

Rapid analysis of flowing blood has the potential to precisely identify the presence and source of blood clotting problems. Personalized management of blood clotting problems within the critical decision making window can lead to fewer patient complications, improved clinical outcomes, and reduced healthcare costs.

Industry: Health
Status: Active
County: Philadelphia

Contact Information

https://flobiollc.com/

Jerri Ann Thatcher

CEO

Mark Kunkel

Product Development Lead

Gary Feiss

Product Development/Regulatory Consultant

Jason Rossi

Co-Inventor

Bhavana Mohanraj

Business Advisor